Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial

被引:13
|
作者
Pulewka, Kristin [1 ,8 ]
Wolff, Daniel [2 ]
Herzberg, Philipp Y. [3 ]
Greinix, Hildegard [4 ]
Heussner, Pia [5 ]
Mumm, Friederike H. A. [5 ]
von Harsdorf, Stephanie [6 ]
Rieger, Kathrin [7 ]
Hemmati, Philipp [7 ]
Hochhaus, Andreas [8 ]
Hilgendorf, Inken [8 ]
机构
[1] Univ Hosp Jena, Inst Psychosocial Med & Psychotherapy, Jena, Germany
[2] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany
[3] Helmut Schmidt Univ, Fed Armed Forces Hamburg, Personal Psychol & Psychol Assessment, Fac Humanities & Social Sci, Hamburg, Germany
[4] Med Univ Graz, Div Hematol, Dept Internal Med 1, Graz, Austria
[5] Ludwig Maximilians Univ Munchen, Dept Internal Med 3, Psychooncol, Klinikum Grosshadern, Munich, Germany
[6] Univ Ulm, Dept Internal Med 3, Ulm, Germany
[7] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[8] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Klinikum 1, D-07740 Jena, Germany
关键词
Adolescents and young adults (AYA); Stem-cell transplantation; Quality of life; Psycho-oncology; QUALITY-OF-LIFE; HUMAN ACTIVITY PROFILE; TERM-FOLLOW-UP; CANCER SURVIVORS; MARROW-TRANSPLANTATION; CARE; VALIDATION; DISTRESS; SUPPORT; INTERVENTIONS;
D O I
10.1007/s00432-017-2424-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Allogeneic hematopoietic stem-cell transplantation (alloHSCT) is physically and psychosocially demanding. Among transplant recipients, adolescent and young adults (AYA) represent a special group, as disease occurs early in life, resulting in the prospect of long survival time and high burden of alloHSCT sequelae. However, data focusing on AYA undergoing alloHSCT are rare. Methods Data resulting from a prospective multicenter trial initially focusing on graft-versus-host disease (GvHD) after alloHSCT were reused to analyse the differences between AYA and elderly patients. In total, data of 205 alloHSCT recipients were evaluated. Patients completed the FACTBMT, HAP, SF-36, 24-AM, LOT-R, BSSS, HADS, and GvHD questionnaires. Results Median age of AYA and non-AYA patients was 29 and 52 years. Using 24-AM-Test, evaluating personality traits, non-AYA reported to be more conscientious (p = 0.033). However, AYA described higher quality of life regarding physical role functioning (p = 0.001), physical functioning (p = 0.002), bodily pain (p = 0.023), and emotional role function (p = 0.027) in the SF-36. General health perception, vitality, social role functioning, and mental health were comparable among both groups. On HAP scale, AYA reported higher maximum (p = 0.003) and adjusted activity scores (p = 0.002), but showed similar restrictions regarding activity, self-supply, and self-determination. Conclusion AYA represent a particular group characterized by higher physical well-being and activity scores, and significantly vary from non-AYA patients in psychosocial aspects. Studies covering distinctive features of AYA undergoing alloHSCT are warranted to improve awareness of the special needs of this group.
引用
收藏
页码:1613 / 1619
页数:7
相关论文
共 50 条
  • [41] Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation
    Hayakawa, Jin
    Miyamura, Daijiro
    Kimura, Shun-ichi
    Gomyo, Ayumi
    Tamaki, Masaharu
    Akahoshi, Yu
    Harada, Naonori
    Ugai, Tomotaka
    Kusuda, Machiko
    Kameda, Kazuaki
    Wada, Hidenori
    Ishihara, Yuko
    Kawamura, Koji
    Sakamoto, Kana
    Sato, Miki
    Terasako-Saito, Kiriko
    Kikuchi, Misato
    Nakasone, Hideki
    Kako, Shinichi
    Kanda, Yoshinobu
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 994 - 1003
  • [42] Quality of life in oncological and hematooncological patients after hematopoietic stem cell transplantation: The effect of selected psychosocial and health aspects on quality of life: A review of the literature
    Slovacek, Ladislav
    Slovackova, Birgita
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (01) : 53 - 59
  • [43] Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
    Lin, Chenyu
    Schwarzbach, Aurelie
    Montesinos, Pau
    Stiff, Patrick
    Cutler, Corey
    Parikh, Suhag
    Brunstein, Claudio
    Lindemans, Caroline A.
    Hanna, Rabi
    Koh, Liang Piu
    Maziarz, Richard T.
    Keating, Amy K.
    Huang, William Y. K.
    Rezvani, Andrew R.
    Valcarcel, David
    Fernandes, Juliana F.
    Badell, Isabell S.
    Jagasia, Madan H.
    Frankfurt, Olga
    Ram, Ron
    McGuirk, Joseph P.
    Kurtzberg, Joanne
    Sanz, Guillermo
    Simantov, Ronit
    Horwitz, Mitchell E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S442 - S442
  • [44] Palliative care in allogeneic hematopoietic stem-cell transplanted patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
    Polomeni, Alice
    Prod'homme, Chloe
    Ainaoui, Malika
    Bellec, Adeline
    Berr, Aurelie
    Bonneau, Jacinthe
    Charbonnier, Amandine
    Coiteux, Valerie
    de Berranger, Eva
    Descamps, Thomas
    Gire, Marion
    Goncalves, Murielle
    Ruscassie, Agnes
    Yakoub-Agha, Ibrahim
    Borel, Cecile
    BULLETIN DU CANCER, 2021, 108 (12) : S1 - S9
  • [45] Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study
    Yadav, Hemang
    Herasevich, Svetlana
    Zhang, Zhenmei
    White, Bradley A.
    Torghabeh, Mehrdad Hefazi
    Hogan, William J.
    Schulte, Philip J.
    Niven, Alexander S.
    Gajic, Ognjen
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 942 - 949
  • [46] Fertility After Allogeneic Hematopoietic Stem Cell Transplantation: A 23-Year Review From A Tertiary Hospital
    Atilla, Pinar Ataca
    Atilla, Erden
    Ediboglu, Elif
    Bozdag, Sinem C.
    To-Prak, Selami K.
    Arslan, Onder
    Ozcan, Muhit
    Gurman, Gunhan
    Topcuoglu, Pervin
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (03): : 145 - 152
  • [47] Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial
    El-Jawahri, Areej
    Traeger, Lara
    Greer, Joseph A.
    VanDusen, Harry
    Fishman, Sarah R.
    LeBlanc, Thomas W.
    Pirl, William F.
    Jackson, Vicki A.
    Telles, Jason
    Rhodes, Alison
    Li, Zhigang
    Spitzer, Thomas R.
    McAfee, Steven
    Chen, Yi-Bin A.
    Temel, Jennifer S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) : 3714 - +
  • [48] Psychometric properties of the Activities Ccale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium
    Lawitschka, Anita
    Brunmair, Matthias
    Bauer, Dorothea
    Zubarovskaya, Natalia
    Felder-Puig, Rosemarie
    Strahm, Brigitte
    Bader, Peter
    Strauss, Gabriele
    Albert, Michael
    von Luettichau, Irene
    Greinix, Hildegard
    Wolff, Daniel
    Peters, Christina
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 41 - 51
  • [49] Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
    Ben Hassine, Khalil
    Nava, Tiago
    Theoret, Yves
    Nath, Christa E.
    Daali, Youssef
    Kassir, Nastya
    Lewis, Victor
    Bredius, Robbert G. M.
    Shaw, Peter J.
    Bittencourt, Henrique
    Krajinovic, Maja
    Uppugunduri, Chakradhara Rao Satyanarayana
    Ansari, Marc
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (09): : 1043 - 1056
  • [50] Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
    Lin, Chien-Ting
    Hsueh, Po-Ren
    Wu, Shang-Ju
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Hsu, Cheng-An
    Tang, Jih-Luh
    Tien, Hwei-Fang
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2310 - 2315